Prestige Biologics Co., Ltd. (KOSDAQ:334970)

Prestige Biologics Revenue

Prestige Biologics had revenue of 3.02B KRW in the quarter ending December 31, 2024, with 302.65% growth. This brings the company's revenue in the last twelve months to 3.87B, up 5,496.88% year-over-year. In the fiscal year ending June 30, 2024, Prestige Biologics had annual revenue of 2.17B with 24.24% growth.

• Revenue (ttm): 3.87B
• Revenue Growth: +5,496.88%
• P/S Ratio: 80.04
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 309.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	2.17B	423.21M	24.24%
Jun 30, 2023	1.75B	1.73B	11,115.88%
Dec 31, 2022	15.57M	-3.21B	-99.52%
Dec 31, 2021	3.23B	-	-
Dec 31, 2020	-	-	-